Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Louis P. Vézina"'
Publikováno v:
Molecular Plant-Microbe Interactions, Vol 13, Iss 11, Pp 1271-1274 (2000)
P121R25 is a Tn5-induced mutant of the effective Rhizobium leguminosarum bv. phaseoli strain P121R that is unable to use glutamate as the sole carbon and nitrogen source and is defective in symbiotic nitrogen fixation. Enzymatic analysis showed that
Externí odkaz:
https://doaj.org/article/63fb33860ea2478a9fac54cd2bd1a547
Autor:
Charlotte Castenmiller, MSc, Noémi Anna Nagy, MD, Pascal Zion Kroon, MSc, Lydia Auger, Réjean Desgagnés, MSc, Caroline Martel, MSc, Lucie Mirande, MSc, Bertrand Morel, PhD, Joannie Roberge, MSc, Virginie Stordeur, MSc, Guy Tropper, MD, FRCSC, Louis Philipe Vézina, PhD, Ronald van Ree, PhD, Véronique Gomord, PhD, Esther Christina de Jong, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 11, Pp 100839- (2023)
Introduction: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Pean
Externí odkaz:
https://doaj.org/article/c3fad01a171e4c52b03b29161048e6f2
Autor:
Véronique Gomord, Virginie Stordeur, Anne-Catherine Fitchette, Elizabeth D Fixman, Guy Tropper, Lorna Garnier, Réjean Desgagnes, Sébastien Viel, Julie Couillard, Guillaume Beauverger, Sylvain Trepout, Brian J Ward, Ronald van Ree, Loic Faye, Louis-P Vézina
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0242867 (2020)
Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained efficacy. However, it is poorly developed compared to symptomatic drugs. The main reasons come from treatment duration implying monthly injections during
Externí odkaz:
https://doaj.org/article/c2b0a900153542a499e9a163fb495643
Autor:
Cláudio Melo, Louis P. Vézina, Simone Sühnel, Bianca Maria Soares Scaranto, Chris Langdon, Graziela Cleuza Vieira, João Paulo Ramos Ferreira, Matt Hawkyard, Carlos Henrique Araújo de Miranda Gomes
Publikováno v:
Aquaculture Nutrition. 27:2307-2319
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6778e10e01c8f42ed3f9e52f6d4130c7
https://doi.org/10.1111/anu.13364
https://doi.org/10.1111/anu.13364
HIV-1 Tropism Testing and Clinical Management of CCR5 Antagonists: Quebec Review and Recommendations
Autor:
Cécile Tremblay, Isabelle Hardy, Richard Lalonde, Benoit Trottier, Irina Tsarevsky, Louis-Philippe Vézina, Michel Roger, Mark Wainberg, Jean-Guy Baril
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 24, Iss 4, Pp 202-208 (2013)
HIV-1 tropism assays play a crucial role in determining the response to CCR5 receptor antagonists. Initially, phenotypic tests were used, but limited access to these tests prompted the development of alternative strategies. Recently, genotyping tropi
Externí odkaz:
https://doaj.org/article/e2b3178833b247dca57c543117993fe1
Autor:
Nathalie Landry, Brian J Ward, Sonia Trépanier, Emanuele Montomoli, Michèle Dargis, Giulia Lapini, Louis-P Vézina
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15559 (2010)
UnlabelledThe recent swine H1N1 influenza outbreak demonstrated that egg-based vaccine manufacturing has an Achille's heel: its inability to provide a large number of doses quickly. Using a novel manufacturing platform based on transient expression o
Externí odkaz:
https://doaj.org/article/ca8e93613f84474b8fe3ee1da465d892
Autor:
Teunis B. H. Geijtenbeek, Véronique Gomord, Louis-P. Vézina, G. Tropper, Virginie Stordeur, M. Bérubé, Lorenz Aglas, S. Busold, Réjean Desgagnés, C. Martel, R. Van Ree
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:S26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daa9f8efb278dbb26417ae50b97f8263
https://doi.org/10.1016/j.anai.2021.08.078
https://doi.org/10.1016/j.anai.2021.08.078
Autor:
G. Tropper, Anne-Catherine Fitchette, Véronique Gomord, Virginie Stordeur, Loïc Faye, Sébastien Viel, G. Beauverger, Elizabeth D. Fixman, R. Van Ree, Lorna Garnier, Louis-P. Vézina, S. Busold
Publikováno v:
Revue Française d'Allergologie. 60:382-383
Introduction L’immunotherapie allergenique actuelle implique des traitements longs et des questions se posent quant a sa capacite reelle a peser sur la pandemie d’allergie. Aujourd’hui, de nouvelles formes d’immunotherapie basee sur l’utili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe6ff30d774c1273103f44497ea7c5bd
https://doi.org/10.1016/j.reval.2020.02.221
https://doi.org/10.1016/j.reval.2020.02.221
Autor:
G. Beauverger, Virginie Stordeur, Louis-P. Vézina, Réjean Desgagnés, Sylvain Trépout, Elizabeth D. Fixman, Loïc Faye, R. Van Ree, Véronique Gomord, Lorna Garnier, Sébastien Viel, Julie Couillard, G. Tropper, Anne-Catherine Fitchette
Publikováno v:
Revue Française d'Allergologie. 61:300
Introduction L’immunotherapie allergenique (AIT) est le seul traitement de l’allergie avec des preuves d’efficacite durable. Cependant, ce traitement est peu developpe par rapport aux traitements symptomatiques. Les principales raisons provienn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ced23b4f94ae5a7b5519d20e6f1c2b6
https://doi.org/10.1016/j.reval.2021.03.175
https://doi.org/10.1016/j.reval.2021.03.175
Autor:
Julie Couillard, Réjean Desgagnés, Sylvain Trépout, Guillaume Beauverger, G. Tropper, Virginie Stordeur, Anne-Catherine Fitchette, Elizabeth D. Fixman, Ronald van Ree, Louis-P. Vézina, Loïc Faye, Brian J. Ward, Lorna Garnier, Véronique Gomord, Sébastien Viel
Publikováno v:
PLoS ONE
PLoS ONE, 15(12 December):e0242867. Public Library of Science
PLoS ONE, Vol 15, Iss 12, p e0242867 (2020)
PLoS ONE, 15(12 December):e0242867. Public Library of Science
PLoS ONE, Vol 15, Iss 12, p e0242867 (2020)
Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained efficacy. However, it is poorly developed compared to symptomatic drugs. The main reasons come from treatment duration implying monthly injections during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a94369b1ab91ea0ed27c7f179bf512
https://doi.org/10.1371/journal.pone.0242867
https://doi.org/10.1371/journal.pone.0242867